Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.33 |
| ▸ | PNMT | P11086 | 1/20 | 0.33 |
| ▸ | CD44 | P16070 | 1/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.33 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27663729 | 0.76 | HTR2A (0.38) | HTR2AHTR2CTSHRTDP1MEN1 | |
| SCHEMBL27963000 | 0.76 | HTR2A (0.38) | HTR2AHTR2CTSHRTDP1MEN1 | |
| SCHEMBL27977681 | 0.76 | HTR2A (0.38) | HTR2AHTR2CTSHRTDP1MEN1 | |
| SCHEMBL27969609 | 0.76 | HTR2A (0.38) | HTR2AHTR2CTSHRTDP1MEN1 | |
| SCHEMBL11488652 | 0.76 | HTR2A (0.43) | HTR2AHTR2CTSHRTDP1MEN1 | |
| SCHEMBL1413826 | 0.73 | HDAC9 (0.37) | HTR2AHTR2CTSHRTDP1MEN1 | |
| Bromide SCHEMBL28138227 | 0.72 | HDAC9 (0.36) | HTR2AHTR2CTSHRTDP1MEN1 | |
| SCHEMBL2227079 | 0.71 | HTR2A (0.40) | HTR2AHTR2CTSHRMEN1MAOB | |
| SCHEMBL28008899 | 0.71 | ALDH1A1 (0.39) | HTR2AHTR2CTSHRTDP1MEN1 | |
| SCHEMBL28043614 | 0.71 | HTR2A (0.34) | HTR2AHTR2CTSHRTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103958478-A | Novel bicyclic dihydroisoquinolin-1-one derivatives | HOFFMANN LA ROCHE | 2014-07-30 | — | — | CN | claimed |
| CN-108617166-A | Protein Kinase Inhibitor Benzolactam Compounds | 大冢制药株式会社 | 2018-10-02 | — | — | CN | disclosed |
| CN-105143204-B | The ketone of 3,4 dihydro 2H isoquinolin 1 and the assimilation compound of 2,3 xylylenimine 1 | 豪夫迈·罗氏有限公司 | 2018-02-02 | — | — | CN | disclosed |
| CN-105143205-B | The new ketone of 3,4 dihydro 2H isoquinolin 1 and the assimilation compound of 2,3 xylylenimine 1 | 豪夫迈·罗氏有限公司 | 2018-02-02 | — | — | CN | disclosed |
| CN-107072985-A | Therapeutic inhibiting compound | 莱福斯希医药公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-103958478-A | Novel bicyclic dihydroisoquinolin-1-one derivatives | HOFFMANN LA ROCHE | 2014-07-30 | — | — | CN | disclosed |
| CN-103108871-A | 17a-hydroxylase/c17,20-lyase inhibitors | NOVARTIS AG | 2013-05-15 | — | — | CN | disclosed |